Biosimilars: A revolution for biologics in the pharmaceutical industry
This project report is submitted in partial fulfilment of the requirements for the degree of Bachelor of Pharmacy, 2017.
| 主要作者: | |
|---|---|
| 其他作者: | |
| 格式: | Project report |
| 语言: | English |
| 出版: |
BRAC University
2018
|
| 主题: | |
| 在线阅读: | http://hdl.handle.net/10361/9331 |
| id |
10361-9331 |
|---|---|
| record_format |
dspace |
| spelling |
10361-93312019-09-30T03:16:48Z Biosimilars: A revolution for biologics in the pharmaceutical industry Moreino, Shannon Sherwin Kabir, Eva Rahman Department of Pharmacy, BRAC University Pharmaceutical industry Biosimilars Biological products This project report is submitted in partial fulfilment of the requirements for the degree of Bachelor of Pharmacy, 2017. Cataloged from PDF version of project report. Includes bibliographical references (page 71-76). The high demand for and resulting financial success of biopharmaceutical products over the last three decades have seen the door open for close copies of these biological products. Popularly termed as biosimilars, these products hold immense potential for the pharmaceutical industry in terms of their applications and benefits. Biosimilars also pose to be of great promise to the Bangladesh pharmaceutical industry, with the commitment of drastically reducing its dependence on foreign imports of biopharmaceutics to meet local demand. Biosimilars have the additional advantage of requiring an abbreviated and streamlined approval process by a recognized regulatory body and are commercialized only after they have undergone clinical evaluation to verify that they are highly similar to already approved reference products. This paper seeks to provide an overview of biosimilar drugs and collate all relevant published data to assess the weight of available evidence that this new frontier holds promise for development in the drug industry. Furthermore, it aims to investigate the prospects of biosimilar development, employment and education within Bangladesh. Shannon Sherwin Moreino B. Pharmacy 2018-02-01T06:25:45Z 2018-02-01T06:25:45Z 2017 2017-08-23 Project report ID 12146040 http://hdl.handle.net/10361/9331 en BRAC University project reports are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission. 91 pages application/pdf BRAC University |
| institution |
Brac University |
| collection |
Institutional Repository |
| language |
English |
| topic |
Pharmaceutical industry Biosimilars Biological products |
| spellingShingle |
Pharmaceutical industry Biosimilars Biological products Moreino, Shannon Sherwin Biosimilars: A revolution for biologics in the pharmaceutical industry |
| description |
This project report is submitted in partial fulfilment of the requirements for the degree of Bachelor of Pharmacy, 2017. |
| author2 |
Kabir, Eva Rahman |
| author_facet |
Kabir, Eva Rahman Moreino, Shannon Sherwin |
| format |
Project report |
| author |
Moreino, Shannon Sherwin |
| author_sort |
Moreino, Shannon Sherwin |
| title |
Biosimilars: A revolution for biologics in the pharmaceutical industry |
| title_short |
Biosimilars: A revolution for biologics in the pharmaceutical industry |
| title_full |
Biosimilars: A revolution for biologics in the pharmaceutical industry |
| title_fullStr |
Biosimilars: A revolution for biologics in the pharmaceutical industry |
| title_full_unstemmed |
Biosimilars: A revolution for biologics in the pharmaceutical industry |
| title_sort |
biosimilars: a revolution for biologics in the pharmaceutical industry |
| publisher |
BRAC University |
| publishDate |
2018 |
| url |
http://hdl.handle.net/10361/9331 |
| work_keys_str_mv |
AT moreinoshannonsherwin biosimilarsarevolutionforbiologicsinthepharmaceuticalindustry |
| _version_ |
1814309551170650112 |